Categories: BioTechDevelopmentDrugManufacturingPlatformProductionTime
Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.
Investors 1
Mentions in press and media 4
| Date | Title | Description |
| 04.09.2025 | Sunflower Therapeutics Receives NIH SBIR Funding | Sunflower Therapeutics, a Medford, MA-based public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, received Small Business Innovation Research (SBIR) grant of up to $2.36M from the ... |
| 20.02.2025 | 5 Minutes with A Future Food VC: Alwyn Capital’s Heather Courtney | 4 Mins Read In our new interview series, we quiz future food investors about the solutions that excite them the most, their favourite climate-forward restaurant, and what they look for in successful founders. Heather Courtney is General Par... |
| 08.10.2024 | Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions | SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology.
With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, in... |
| - | Sunflower Therapeutics | “Sunflower Therapeutics is a biotechnology company delivering next-generation protein manufacturing solutions designed for anyone to use anywhere.” |
Reviews 0
